Rimbach-Zotzenbach, Germany

Ulfert Deneke


Average Co-Inventor Count = 4.3

ph-index = 11

Forward Citations = 625(Granted Patents)


Location History:

  • Morlenbach, DE (1986)
  • Peissenberg, DE (1978 - 1992)
  • Rimbach-Zolzenbach, DE (1993)
  • Rimbach-Zotzenbach, DE (1987 - 2001)
  • Rimbach, DE (2007)

Company Filing History:


Years Active: 1978-2007

Loading Chart...
22 patents (USPTO):Explore Patents

Title: Ulfert Deneke: Innovating Cholesterol Determination Methods

Introduction

Ulfert Deneke, an accomplished inventor based in Rimbach-Zotzenbach, Germany, has made significant contributions to the field of biomedical diagnostics, holding a remarkable total of 22 patents. His innovations focus primarily on methods and apparatuses for determining various cholesterol levels in biological fluid samples.

Latest Patents

Deneke's latest contributions include two notable patents. The first patent describes a method for the determination of HDL cholesterol using a rapid diagnostic agent with an integrated fractionating step. This apparatus features a first and second porous carrier, designed specifically for evaluating biological fluid samples. It effectively separates non-high-density lipoprotein (non-HDL) from a body sample and enables the determination of high-density lipoprotein (HDL) cholesterol.

The second patent details a method for separating non-HDLs from HDLs and determining HDL cholesterol. This invention employs a carrier that allows liquids to flow through it, incorporating a precipitating agent that targets non-high-density lipoproteins (non-HDLs) in biological fluids.

Career Highlights

Throughout his impressive career, Ulfert Deneke has worked with reputable companies in the biotechnology and diagnostics sectors. Notably, he has been associated with Boehringer Mannheim GmbH and Roche Diagnostics GmbH. These affiliations have provided him with a solid platform to develop his innovative techniques and patents in cholesterol determination.

Collaborations

Deneke has collaborated with esteemed professionals in his field, including Walter Rittersdorf and Hartmut Merdes. These partnerships have undoubtedly played a crucial role in the development and refinement of his patented technologies, further enhancing their efficacy and application in the medical diagnostics industry.

Conclusion

Ulfert Deneke's substantial patent portfolio and his innovative methods for cholesterol determination mark him as a significant figure in the field of biomedical diagnostics. His work not only contributes to advancements in medical technology but also improves the accuracy of cholesterol assessments, ultimately promoting better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…